📣 VC round data is live. Check it out!

West Pharma Valuation Multiples

Discover revenue and EBITDA valuation multiples for West Pharma and similar public comparables like Steris, Terumo, Fresenius, Straumann Group and more.

West Pharma Overview

About West Pharma

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.


Founded

1923

HQ

United States

Employees

10.8K

Financials (LTM)

Revenue: $3B
EBITDA: $833M

EV

$23B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

West Pharma Financials

West Pharma reported last 12-month revenue of $3B and EBITDA of $833M.

In the same LTM period, West Pharma generated $1B in gross profit, $833M in EBITDA, and $558M in net income.

Revenue (LTM)


West Pharma P&L

In the most recent fiscal year, West Pharma reported revenue of $3B and EBITDA of $784M.

West Pharma is profitable as of last fiscal year, with gross margin of 36%, EBITDA margin of 26%, and net margin of 17%.

See analyst estimates for West Pharma
LTMLast FY202320242025202620272028
Revenue$3B$3B$3B$3B$3B
Gross Profit$1B$1B$1B$999M$1B
Gross Margin37%36%38%35%36%
EBITDA$833M$784M$844M$744M$773M
EBITDA Margin26%26%29%26%25%
EBIT Margin21%21%24%20%21%
Net Profit$558M$530M$593M$493M$494M
Net Margin18%17%20%17%16%

Financial data powered by Morningstar, Inc.

West Pharma Stock Performance

West Pharma has current market cap of $23B, and enterprise value of $23B.

Market Cap Evolution


West Pharma's stock price is $322.30.

West Pharma share price increased by 8.3% in the last 30 days, and by 52.9% in the last year.

West Pharma has an EPS (earnings per share) of $7.50.

See more trading valuation data for West Pharma
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$23B$23B-1.1%8.3%26.7%52.9%$7.50

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

West Pharma Valuation Multiples

West Pharma trades at 7.1x EV/Revenue multiple, and 27.1x EV/EBITDA.

See NTM and 2027E valuation multiples for West Pharma

EV / Revenue (LTM)


West Pharma Financial Valuation Multiples

As of May 12, 2026, West Pharma has market cap of $23B and EV of $23B.

West Pharma has a P/E ratio of 40.8x.

LTMLast FY202320242025202620272028
EV/Revenue7.1x7.3x7.6x7.8x7.3x
EV/EBITDA27.1x28.8x26.7x30.3x29.2x
EV/EBIT34.0x35.5x31.9x38.2x35.5x
EV/Gross Profit19.5x20.4x20.0x22.6x20.4x
P/E40.8x43.0x38.4x46.2x46.1x
EV/FCF47.7x48.1x54.4x81.6x48.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified West Pharma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

West Pharma Margins & Growth Rates

West Pharma grew revenue by 8% and EBITDA by 17% in the last fiscal year.

In the most recent fiscal year, West Pharma reported gross margin of 36%, EBITDA margin of 26%, and net margin of 17%.

See estimated margins and future growth rates for West Pharma

West Pharma Margins

Last FY202420252026202720282029
Gross Margin36%35%36%37%
EBITDA Margin26%26%25%28%
EBIT Margin21%20%21%22%
Net Margin17%17%16%18%
FCF Margin15%10%15%14%

West Pharma Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth8%(2%)6%8%
Gross Profit Growth13%(12%)11%13%
EBITDA Growth17%(12%)4%19%
EBIT Growth15%(16%)8%15%
Net Profit Growth15%(17%)0%23%
FCF Growth2%(33%)70%2%

Data powered by FactSet, Inc. and Morningstar, Inc.

West Pharma Operational KPIs

West Pharma's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.0M for the same period.

West Pharma's Rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

West Pharma's Rule of X is 48% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for West Pharma
LTMLast FY202320242025202620272028
Rule of 4034%36%———
Bessemer Rule of X45%48%———
Revenue per Employee—$0.3M———
Opex per Employee—$0.0M———
S&M Expenses to Revenue13%13%——13%
R&D Expenses to Revenue2%2%2%2%2%
Opex to Revenue—15%14%14%15%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

West Pharma Competitors

West Pharma competitors include Steris, Terumo, Fresenius, Straumann Group, Mindray, Smith & Nephew, Medline, Fresenius Medical Care, Baxter International and AptarGroup.

Most West Pharma public comparables operate across Medical Supplies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Steris3.9x3.6x15.8x12.8x
Terumo2.7x2.7x11.7x11.0x
Fresenius1.4x1.3x8.3x8.2x
Straumann Group5.0x5.0x16.5x16.4x
Mindray5.6x5.5x16.4x16.8x
Smith & Nephew2.5x2.4x9.7x9.4x
Medline1.5x1.5x12.6x12.4x
Fresenius Medical Care1.0x1.0x5.4x5.4x

This data is available for Pro users. Sign up to see all West Pharma competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About West Pharma

When was West Pharma founded?West Pharma was founded in 1923.
Where is West Pharma headquartered?West Pharma is headquartered in United States.
How many employees does West Pharma have?As of today, West Pharma has over 10K employees.
Who is the CEO of West Pharma?West Pharma's CEO is Eric Mark Green.
Is West Pharma publicly listed?Yes, West Pharma is a public company listed on NYSE.
What is the stock symbol of West Pharma?West Pharma trades under WST ticker.
When did West Pharma go public?West Pharma went public in 1973.
Who are competitors of West Pharma?West Pharma main competitors include Steris, Terumo, Fresenius, Straumann Group, Mindray, Smith & Nephew, Medline, Fresenius Medical Care, Baxter International, AptarGroup.
What is the current market cap of West Pharma?West Pharma's current market cap is $23B.
What is the current revenue of West Pharma?West Pharma's last 12 months revenue is $3B.
What is the current revenue growth of West Pharma?West Pharma revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of West Pharma?Current revenue multiple of West Pharma is 7.1x.
Is West Pharma profitable?Yes, West Pharma is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of West Pharma?West Pharma's last 12 months EBITDA is $833M.
What is West Pharma's EBITDA margin?West Pharma's last 12 months EBITDA margin is 26%.
What is the current EV/EBITDA multiple of West Pharma?Current EBITDA multiple of West Pharma is 27.1x.
What is the current FCF of West Pharma?West Pharma's last 12 months FCF is $473M.
What is West Pharma's FCF margin?West Pharma's last 12 months FCF margin is 15%.
What is the current EV/FCF multiple of West Pharma?Current FCF multiple of West Pharma is 47.7x.
How many companies West Pharma has acquired to date?West Pharma hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies West Pharma has invested to date?West Pharma hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to West Pharma

Lists including West Pharma

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial